Duke University: Anemia, Sickle Cell trials

The registry lists 27 Anemia, Sickle Cell studies with Duke University as lead sponsor. 2 are open to participants now and 8 have results posted.

Phase 1 1Phase 2 2Phase 3 1Phase 4 4No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SickleFit Exercise and Nutrition StudyRecruitingNCT07442851Not applicable
• Predictors of Pain in Sickle Cell DiseaseRecruitingNCT06139510Not applicable
• Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)CompletedNCT05714098Not applicableResults posted
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic ConditionsCompletedNCT03938324Not applicableResults posted
• Comparing Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell DiseaseTerminatedNCT03933397Phase 3Results posted
• Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)TerminatedNCT03387033Not applicableResults posted
• Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)CompletedNCT03178643Phase 4Results posted
• Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent TransfusionsCompletedNCT02731157Phase 4Results posted
• Comparing Acute Pain Management Protocols for Patients With Sickle Cell DiseaseCompletedNCT02222246Phase 4Results posted
• Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus PlaceboCompletedNCT01419977Phase 2Results posted
• COVID-19 Vaccination Hesitancy in Adults With Sickle Cell DiseaseCompletedNCT05998824Not applicable
• Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell DiseaseCompletedNCT04584528Not applicable
• Ketamine Infusion for Sickle Cell Pain CrisisWithdrawnNCT04005209Phase 4
• Stigma, Self-management, & Quality of Life in SCDCompletedNCT03488264
• Disseminating NIH Evidence Based Sickle Cell Recommendations in North CarolinaCompletedNCT03253211
• Improving Sickle Cell Disease (SCD) Care Using Web-based GuidelinesCompletedNCT03037021
• SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital DischargeCompletedNCT02475993Not applicable
• MBSR for Pain Catastrophizing in SCDCompletedNCT02394587Not applicable
• Use of Mobile Technology for Intensive Training in Medication ManagementCompletedNCT02133560Not applicable
• Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell DiseaseCompletedNCT01895998Phase 1
• Use of a Mobile-based App for SCD PatientsCompletedNCT01833702
• Cognitive Rehabilitation in Sickle Cell DiseaseCompletedNCT01793740Not applicable
• Microvascular and Fibrosis Imaging StudyCompletedNCT01758250
• Improving Emergency Department Management of Adults With Sickle Cell DiseaseCompletedNCT01603160
• Adherence to Hydroxyurea in Children With Sickle Cell AnemiaCompletedNCT00672789Not applicable
• Hydroxyurea in Young Children With Sickle Cell AnemiaCompletedNCT00519701Not applicable
• Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow VelocityCompletedNCT00402480Phase 2